Mutual of America Capital Management LLC Has $4.84 Million Stake in Encompass Health Co. (NYSE:EHC)

Mutual of America Capital Management LLC decreased its stake in Encompass Health Co. (NYSE:EHC) by 5.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,583 shares of the company’s stock after selling 4,399 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Encompass Health were worth $4,843,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of EHC. McGlone Suttner Wealth Management Inc. acquired a new stake in Encompass Health in the 4th quarter valued at $30,000. C M Bidwell & Associates Ltd. acquired a new position in Encompass Health in the third quarter worth $35,000. Worth Asset Management LLC acquired a new position in Encompass Health in the first quarter worth $35,000. Belpointe Asset Management LLC boosted its stake in Encompass Health by 88.2% in the first quarter. Belpointe Asset Management LLC now owns 781 shares of the company’s stock worth $42,000 after purchasing an additional 366 shares in the last quarter. Finally, Quarry LP acquired a new position in Encompass Health in the first quarter worth $42,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Stephens reissued an “overweight” rating and issued a $85.00 price objective on shares of Encompass Health in a research note on Tuesday, January 16th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Truist Financial boosted their price objective on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Royal Bank of Canada restated an “outperform” rating and set a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Finally, Mizuho boosted their target price on Encompass Health from $77.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and an average target price of $83.22.

Encompass Health Trading Down 1.4 %

NYSE EHC opened at $80.49 on Monday. The stock has a 50-day simple moving average of $76.68 and a 200 day simple moving average of $69.91. The company has a market capitalization of $8.06 billion, a PE ratio of 23.20, a P/E/G ratio of 1.49 and a beta of 0.94. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19. Encompass Health Co. has a 12 month low of $57.55 and a 12 month high of $83.73.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, February 7th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.12. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. Research analysts forecast that Encompass Health Co. will post 3.96 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, April 15th. Investors of record on Monday, April 1st will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a yield of 0.75%. Encompass Health’s dividend payout ratio is presently 17.29%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.